NEW YORK (MainStreet) The inventor of pre-Alzheimer's EEG testing and the eForex trading platform has launched a biotech company poised to enlighten growers, physicians and consumers about the intricacies of cannabis seeds and strains.
"It's an organic extension of all technologies which we have been developing for more than 15 years in artificial intelligence, EEG and DNA," said Boris Goldstein, who launched PotBotics in October 2013. "We want to help patients get better consulting and advice when considering medical Marijuana."
A division of PotBotics, BrainBotics will license EEG hardware to doctors and give feedback through a centralized location.
"It's a helmet that helps physicians who prescribe marijuana to make better informed decisions through the EEG scanning of alpha brain waves of the patient," Goldstein told MainStreet. "The software reads the images that the helmet provides. Doctors can then use the information to prescribe a more specific strain of cannabis for different ailments."
Another division of the company is NanoPot, a DNA diagnostics service of cannabis seeds for the purpose of providing growers with customized grow plans that include irrigation, lighting and UV filters.
Also see: Marijuana Saved My Life: An Abbreviated Dope Diary
"There are hundreds of pot strains from hybrids, hydroponics and outdoor growing," said David Goldstein, director of communications with PotBotics. "Our clients will get a fully integrated growth plan that can raise their yield of cannabis by 20%."
PotBotics will be listed on the penny stock exchange in four to five months upon the completion of the acquisition of an existing medical company listed on the Over the Counter (OTC) Bulletin Board.
"There is added value in the medical company we are acquiring," said David Goldstein. "We are building a stronger management team with board members and investment bankers supporting this merger."
Ever the skeptic, penny stock trader and entrepreneur Timothy Sykes is leery.